All News

2060 articles, sorted by publication time.

Cancer Diagnostics · global

Waiting Two More Days to Scan: GTH Evaluates Investment in Zirconium-89 Prostate Cancer Imaging Startup

When PSA signals recurrence but imaging cannot locate a lesion, delaying the scan may offer another clue. Zirnostics’ zirconium-89 tracer technology has drawn GTH’s interest in a potential equity investment, but preliminary lesion detection findings remain some distance from marketing authorization and proof of treatment benefit.

Cancer Immunology and Cell Therapy · us

Helping Cancer-Fighting T Cells Last Longer: CRISPR Screen Identifies CRL5 as a Target for Regulating Exhaustion

Immune cells may gradually lose their fighting capacity after repeated encounters with tumors. A UCLA study found that disrupting components of the CRL5 complex could improve sustained function in engineered T cells and tumor control in mice, offering a new lead for cell therapies for solid tumors; whether patients can benefit awaits clinical validation.